Two Medtech top managers join the Board of Aeon Scientific

Aeon Scientific is a Zurich based medical device company founded in 2010 with the goal to become a technology leader for wirelessly controlled devices within the human body. The company was able to attract two experienced board members.

Max Link who will serve as Chairman of the Board was CEO and Chairman of the Board of Centerpulse AG, a medical implant company, from March 2001 to September 2003. He started his career at Sandoz. From 1987 to 1992, Link was Chief Executive Officer of Sandoz Pharma and member of the Executive Board of Sandoz, Ltd., Basel. From 1992 to 1993, Dr. Link was Chairman of the Board of Sandoz. From May 1993 to June 1994, Link was Chief Executive Officer of Corange (Bermuda), the parent company of Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy Orthopedics. Today, Link is a director of Discovery Labs, Inc. and Human Genome Sciences, Inc., each a publicly held pharmaceutical and/or life-science company.

Gerd Meyer has over 28 years of experience in the pharmaceutical and medical device industry. He served most recently as Head of Global Partnering (BD&L) for General Medicine and Mature Products at Novartis Pharma’s Headquarters in Basel and became Member of Novartis’ Prime Force. Meyer held various senior positions at Novartis HQ in Global Project and Product Management, Marketing Research, Trademarks, and Strategic Planning. He also coordinated the merger between Sandoz and Ciba-Geigy. His books on Human Capital and on Innovations received scientific awards.

“We are happy and honored to welcome Max Link and Gerd Meyer to our Board of Directors. We are convinced that they will contribute to the success of our company with their extensive experience from top management roles in both startups and large companies,” said Dominik Bell, CEO of Aeon Scientific.

Aeon Scientific develops wirelessly controlled devices to be used within the human body. As a focus the company is working on a new type of catheter steering system using its patented technology for electromagnetic manipulation. The system supports electrophysiologists during catheter ablation procedures for the treatment of arrhythmias, such as Atrial Fibrillation. It allows them to move the ablation catheter within the heart of the patient with magnetic fields. The improved control leads to better outcomes, reduced treatment costs and a higher number of patients that can be treated.